Wedbush Comments on Biogen’s Q2 Earnings (NASDAQ:BIIB)
Biogen Inc. (NASDAQ:BIIB – Free Report) – Stock analysts at Wedbush boosted their Q2 2025 earnings per share (EPS) estimates for shares of Biogen in a report released on Wednesday, April 16th. Wedbush analyst L. Chico now expects that the biotechnology company will post earnings per share of $4.21 for the quarter, up from their […]
